Back to search
FDAFDA · Food and drugs·Recall number D-855-2013

BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.

Published August 14, 2013 · Recall initiated: July 31, 2013

Summary

FDA records drug Class III recall D-855-2013, published August 14, 2013 and initiated July 31, 2013. Recalling firm: Actavis Inc; Status: Terminated; Reported quantity: 15,132 bottles; Lot: Lot #: CG2D18A, Exp 06/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis Inc
Distributor
Nationwide and Puerto Rico
Lot
Lot #: CG2D18A, Exp 06/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6. recalled?

Yes. FDA published recall D-855-2013 on August 14, 2013. Reported hazard: Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter